ArticleThe Journal of urology2020
Re: Development and Validation of a Robust Multigene Signature as an Aid to Predict Early Relapse in Stage I-III Clear Cell and Papillary Renal Cell Cancer.
M Pilar LagunaPubMed ↗Publisher ↗
No numbers read from the abstract.